title: Bronchodilators should be considered for all patients with acute bronchiolitis, but closely monitored for objectively measured clinical benefits.
authors.affiliation: Department of Peadiatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia. carerodriguezmar@unal.edu.co.|Department of Peadiatric Pulmonology and Peadiatric Critical Care Medicine, School of Medicine, Universidad El Bosque, Bogota, Colombia. carerodriguezmar@unal.edu.co.|Research Unit, Military Hospital of Colombia, Bogota, Colombia. carerodriguezmar@unal.edu.co.
authors.forename: Carlos E
authors.initials: CE
authors.lastname: Rodriguez-Martinez
authors.affiliation: Departments of Peadiatrics and Family Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
authors.forename: Jose A
authors.initials: JA
authors.lastname: Castro-Rodriguez
mesh_terms: D000208:Acute Disease; D001988:Bronchiolitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D019983:Guideline Adherence; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic
chemical_list: D001993:Bronchodilator Agents